Boosters may be available but it seems Australians prefer to live with the virus, with 97 per cent of adults aged 18-64 now unprotected.
After decades of research, Australians will soon have access to the first vaccine approved for respiratory syncytial virus.
The first study to look at the impact of the pandemic on vaccination rates uncovers a disturbing downward trend in young Australians.
Dr Alan Paul says how Australia values vaccines needs to change, a mindset shift required to view them as important prevention assets.
FOI release reveals exactly what share of Australia’s Covid shots buy-up was won by the four vaccine suppliers.
The TGA has approved Moderna’s latest Covid offering as ATAGI narrows the population it is recommending be vaccinated.
GSK’s shingles vaccine will be publicly funded from next month, five years after an initial request for funding was rejected.
Potential first-in-class product targeting the leading bacterial cause of sepsis that impacts 10 million people globally a year.